Effect of new biological patch in repairing intrauterine adhesion and improving clinical pregnancy outcome in infertile women: study protocol for a randomized controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 23; no. 1; p. 510
• Main Authors: Pang, Wen-Juan, Zhang, Qing, Ding, Hai-Xia, Sun, Ning-Xia, Li, Wen
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 18.06.2022; BioMed Central; BMC
• Subjects: Abortion; Adhesion; Amenorrhea; Care and treatment; Complications and side effects; Embryos; Endometrial fibrosis; Endometrium; Extracellular matrix; Fertility; Health aspects; In vitro fertilization; In vitro fertilization–embryo transfer; Infertility; Injuries; Intrauterine adhesion; Intrauterine devices; IUD; Menstruation; Pregnancy; Reproductive technologies; Ultrasonic imaging; Uterine diseases; Vagina; China
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-022-06428-0

Abstract Background Endometrial fibrosis caused by intrauterine adhesion (IUA) can lead to hypomenorrhea, amenorrhea, and even infertility and abortion. The postoperative recurrence rate of severe IUA remains high, giving rise to low pregnancy rates. An extracellular matrix (ECM) scaffold, a new biological material that can promote cell proliferation and differentiation at lesions, has been widely used in general surgery and neurosurgery. The present study applied ECM scaffolds in obstetrics and gynecology for the first time to improve endometrial fibrosis, repair severe IUA, and improve pregnancy outcomes for infertile patients. Methods This paper presents a prospective randomized single-blind controlled superiority study of infertile women aged ≤40 years with IUA. According to the scoring criteria for IUA established by the American Fertility Society, patients with moderate or severe IUA were randomized into two groups at a ratio of 1:1; patients in the experimental group were treated with an ECM scaffold (small intestinal submucosa [SIS]) + intrauterine balloon, while patients in the control group were treated with an intrauterine balloon only. A hysteroscopic examination of adhesion repair was performed again after 2 months of postoperative hormone replacement therapy. Endometrial tissue was sampled during the two operations, and immunohistochemistry was used to observe endometrial and microvascular proliferation. After thawing and resuscitation, a postoperative frozen embryo transfer was performed on the participants in both groups, and their endometrial thickness, intrauterine volume, endometrial vascularization flow index, endometrial flow index, and uterine artery blood flow resistance were evaluated by 3D ultrasonography. The rates of embryo implantation, clinical pregnancy, and early spontaneous abortion were observed. Discussion The ECM scaffold (SIS) + intrauterine balloon method was able to repair endometrial fibrosis and improve IUA. This new technique represents a novel treatment method for improving the pregnancy outcome of infertile patients with moderate/severe IUA. Trial registration Chinese Clinical Trial Register ChiCTR2100052027 . Registered on October 14, 2021.